Search Within

Olaf Penack

Formats
  1. Meeting Abstract (13)
  2. Journal Article (7)
Groups
  1. Center for Hematologic Malignancies (20)
  2. Department of Medicine (20)
  3. Executive Committee, Center for Hematologic Malignancies (20)
  4. GSK Faculty (20)
  5. Hematologic Malignancies, Division of (20)
  6. Immunology Program Faculty (20)

More Groups

People
  1. Marcel Van Den Brink (20)
  2. Amanda Holland (19)
  3. Il-Kang Na (19)
  4. Odette Smith (18)
  5. Robert Jenq (18)
  6. Sydney Lu (18)

More People

Years
  1. 2011 (2)
  2. 2010 (7)
  3. 2009 (9)
  4. 2008 (2)
Publications
  1. Biology of Blood and Marrow Transplantation (6)
  2. Blood (6)
  3. Bone Marrow Transplantation (2)
  4. Cancer Research (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Elsevier Inc. (6)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. American Society for Clinical Investigation (1)
  6. Oxford University Press (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TRAIL/DR5 interactions are important for thymic damage after allogeneic bone marrow transplantation
    Meeting Abstract

    Na, I. K.; Lu, S. X.; Yim, N. L.; Goldberg, G. L.; Tsai, J.; Rao, U. K.; Smith, O. M.; King, C.; Suh, D.; Hirschhorn-Cymerman, D.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • NOD2 deficiency in experimental GvHD
    Meeting Abstract

    Penack, O.; Smith, O.; Liu, X.; Cunningham, A.; Rao, U.; Jim, N.; Na, I. K.; Holland, A.; Ghosh, A.; Lu, S.; more...
    Bone Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Depletion of vascular endothelial progenitor cells simultaneously ameliorates GvHD and inhibits tumor growth
    Meeting Abstract

    Penack, O.; Henke, E.; Suh, D.; King, C.; Smith, M.; Na, I. K.; Holland, A.; Ghosh, A.; Lu, S.; Feng, R.; more...
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Inhibition of vasculogenesis ameliorates GvHD and tumours after allo-BMT
    Meeting Abstract

    Penack, O.; Henke, E.; Suh, D.; King, C.; Smith, O.; Na, I. K.; Holland, A.; Ghosh, A.; Lu, S.; Jenq, R.; more...
    Bone Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Ceacam1 regulates experimental graft-versus-host-disease
    Meeting Abstract

    Lu, S. X.; Willis, L.; Charbonneau Allard, A. M.; Atallah, R.; Holland, A. M.; Turbide, C.; Hubbard, V. M.; Rotolo, J. A.; Smith, O. M.; Suh, D.; more...
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • The T cell cytolytic molecules fas ligand and trail, the trafficking molecules Ccr9, 7 integrin and psgl1, and the immune modulating molecules ox40 and ceacam1 are required for thymic graft-versus-host disease
    Meeting Abstract

    Lu, S. X.; Na, I. K.; Goldberg, G. L.; Ghosh, A.; Hirschhorn-Cymerman, D.; King, C. G.; Smith, O. M.; Suh, D.; Rao, U.; Yim, N.; more...
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • NOD2 regulates hematopoietic cell function during graft-versus-host disease
    Journal Article

    Penack, O.; Smith, O. M.; Cunningham-Bussel, A.; Liu, X.; Rao, U.; Yim, N.; Na, I. K.; Holland, A. M.; Ghosh, A.; Lu, S. X.; more...
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save
  • Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
    Journal Article

    Jenq, R. R.; King, C. G.; Volk, C.; Suh, D.; Smith, O. M.; Rao, U. K.; Yim, N. L.; Holland, A. M.; Lu, S. X.; Zakrzewski, J. L.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Depletion of vascular endothelial progenitor cells inhibits inflammation
    Meeting Abstract

    Penack, O.; Henke, E.; Suh, D.; King, C.; Smith, M. O.; Na, I. K.; Holland, A.; Ghosh, A.; Lu, S. X.; Jenq, R.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • The T cell cytolytic molecules Fas ligand and TRAIL, the trafficking molecules CCR9, β7 integrin and PSGL-1, and the immune modulating molecules OX40, CEACAM1, and CTLA4 are required for thymic graft-versus-host disease
    Meeting Abstract

    Na, I. K.; Lu, S. X.; Goldberg, G. L.; Hirschhorn Cymerman, D. D.; King, C. G.; Smith, O. M.; Suh, D.; Rao, U.; Yim, N.; Holland, A. M.; more...
    Blood (2008)

    Fulltext@MSK | Save